Natural history of primary biliary cirrhosis

Clinics in Liver Disease

Volumn 7, Issue 4, 2003, Pages 779-794

  Parés, Albert ^a   Rodés, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ASCITES; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CHOLESTASIS; DISEASE COURSE; ESOPHAGUS VARICES; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER TRANSPLANTATION; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; PROTHROMBIN TIME; REVIEW; SURVIVAL; SYMPTOMATOLOGY;

EID: 0141891250     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(03)00100-4     Document Type: Review

References (81)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;355:1570-80.
2. Triger DR, Berg P, Rodés J. Epidemiology of primary biliary cirrhosis. Liver 1984;4:195-200.
3. Parés A, Braguera M, Rodés J, Villagrasa M, Guardia J, Serés I, et al. Epidemiología de la cirrosis biliar primaria en Catalunya. Med Clin (Barc) 1984;82:237-40.
4. Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Sem Liver Dis 1997;17:13-22.
5. Kim WR, Lindor KD, Locke GR, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis is a US community. Gastroenterology 2000;119:1631-6.
6. Sherlock S. Primary biliary cirrhosis (chronic obstructive jaundice). Gastroenterology 1959;37:574-9.
7. Klatskin G, Kantor SS. Mitochondrial antibody in primary biliary cirrhosis. Ann Intern Med 1972;77:533-41.
8. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973;289:674.
9. Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;1044:51-123.
10. Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis: chronic non-suppurative destructive cholangitis. Am J Pathol 1965;46:387-407.
11. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967;60:1257-60.
12. Ludwig J, Dickson ER, McDonald GSA. Staging chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch 1978;379:103-12.
13. Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodés J, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980;236:46-78.
14. Kapelman B, Schaffner F. The natural history of primary biliary cirrhosis. Sem Liver Dis 1981;1:273-81.
15. James O, Watson A, Macklon A. Primary biliary cirrhosis. A revised clinical spectrum. Lancet 1981;1:1278-81.
16. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-90.
17. Parés A, Caballería L, Rodés J, Braguera M, Rodrigo L, García-Plaza A, et al. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. J Hepatol 2000;32:561-6.
18. Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-10.
19. Mitchison HC, Bassendine MF, Hendrik A, Bennet MK, Bird G, Watson AJ, et al. Positive antimitochondrial antibody but normal alkaline phosphatase. Is this primary biliary cirrhosis? Hepatology 1986;6:1279-84.
20. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OFW. Natural history of early primary biliry cirrhosis. Lancet 1996;348:1399-401.
21. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factorin primary biliary cirrhosis. Gut 1979;20:137-40.
22. Parés A, Bruguera M, Rodés J. Cirrosis biliar primaria. Evolución clínica y criterios de valor pronóstico. Gastroenterol Hepatol 1981;4:76-81.
23. Locke III GR, Therneau TM, Ludwig J, Dickson ER, Lindor KD. Time course of histological progression in primary biliary cirrhosis. Hepatology 1996;23:52-6.
24. Poupon RE, Lindor KD, Parés A, Chazoullieres O, Poupon R, Heathcote EJ. Combined analysis of the effect of treatment with ursodeoxycholic acid on histology progression in primary biliary cirrhosis [abstract]. J Hepatol 2003;39:12-6.
25. Fox RA, Scheuer PJ, Sherlock S. Asymptomatic primary biliary cirrhosis. Gut 1973;14:444-8.
26. Long R, Scheuer P, Sherlock S. Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology 1977;72:1204-7.
27. Hanik L, Eriksson S. Presymptomatic primary biliary cirrhosis. Acta Med Scand 1977;202:277-81.
28. Fleming C, Ludwig J, Dickson E. Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine. Mayo Clin Proc 1978;53:587-93.
29. Parés A, Bruguera M, Rodés J. Cirrosis biliar primitiva asintomática. Gastroenterol Hepatol 1979; 2:126-30.
30. Viteri A, Greene Jr J. Asymptomatic primary biliary cirrhosis. South Med J 1980;73:163-5.
31. Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology 1985;89:267-71.
32. Mitchison HC, Lucey MR, Kelly PJ, Neuberger J, Williams R, James OF. Symptom development and prognosis in primary biliary cirrhosis: A study in two centers. Gastroenterology 1990;99:778-84.
33. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1-7.
34. Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol 1989;24:57-64.
35. Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990;25:119-26.
36. Jeffrey GP, Reed WD, Shilkin KB. Primary biliary cirrhosis: clinicopathological characteristics and outcome. J Gastroenterol Hepatol 1990;5:639-45.
37. Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology 1990;98:1567-71.
38. Ginés A, Parés A, Bruguera M, Rodés J. A simple method for assessing timing to liver transplantation in primary biliary cirrhosis[abstract]. J Hepatol 1991;13:s124.
39. Mahl T, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20:707-13.
40. Springer J, Cauch-Dudek K, O'Rourke K, Wanless IR, Heathcote EJ. Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol 1999;94:47-53.
41. Vleggaar FP, Van Buuren HR, Zondervan PE, Ten Kate FKW, Hop WCJ. Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant. Gut 2001;49:276-81.
42. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, et al. Benefitial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial. Gastroenterology 1985;89:1084-91.
43. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1-7.
44. Keiding S, Ericzon BG, Eriksson S, Flatmark A, Hockerstedt K, Isoniemi H, et al. Survival after liver transplantation of patients with primary biliary cirrhosis in the Nordic countries: comparison with expected survival in another series of transplantation and in an international trial of medical treatment. Scand J Gastroenterol 1990;25:11-8.
45. Jeffrey GP, Reed WD, Shilkin KB. Natural history and prognostic variables in primary biliary cirrhosis (PBC) [abstract]. Hepatology 1990;12:955.
46. Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using time-dependent Cox regression model, PBC1 and PBC2 trial groups. Gastroenterology 1993;105:1865-76.
47. Murtaugh PA, Dickson ER, van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, et al. Primary biliary cirrhosis: Prediction of short-term survival based on repeated patient visits. Hepatology 1994;20:126-34.
48. Salmerón JM, Caballería J, Parés A, Caballería L, Bruguera M, Rodés J. El péptido amino-terminal del procolágeno tipo III en la cirrosis biliar primaria. Significado clínico y valor pronóstico. Gastroenterol Hepatol 1989;12:109-13.
49. Beukers R, Van Vanten RA, Schalm SW. Serial determination of type III procollagen amino-propeptides serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis. J Hepatol 1992;14:12-29.
50. Nyberg A, Engstrom-Laurent A, Loof L. Serum hyaluronate in primary biliary cirrhosis: a biochemical marker for progressive liver damage. Hepatology 1988;8:142-6.
51. Lee R, Epstein O, Jauregui H, Sherlock S, Scheuer PJ. Granulomas in primary biliary cirrhosis: a prognostic feature. Gastroenterology 1981;81:983-6.
52. Corpechot C, Carrat F, Poupon R, Poupon RE. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 2002;122:652-8.
53. Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: Response to therapy with ursodeoxycholic acid. Hepatology 2002;35:409-13.
54. Reichen J, Widner T, Cutting J. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model. Hepatology 1991;14:119-23.
55. Clements D, Elias E, McMaster P. Preliminary study of indocyanine green clearance in primary biliary cirrhosis. Scand J Gastroenterol 1991;26:119-23.
56. Kew MC, Varma RR, Dos Dantos HA, Scheuer PJ, Sherlock S. Portal hipertension in primary biliary cirrhosis. Gut 1971;12:830-4.
57. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy AL. A prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history and influence on survival. Gastroenterology 1989;96:1552-9.
58. Navasa M, Parés A, Bruguera M, Caballeria J, Bosch J, Rodés J. Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 1987;5:292-8.
59. Nakanuma Y, Ohta G. Nodular hyperplasia of the liver in primary biliary cirrhosis of early histological stages. Am J Gastroenterol 1987;82:8-10.
60. Colina F, Pinedo F, Solis JA, Moreno D, Nevado M. Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis. Gastroenterology 1992;102:1319-24.
61. Graham DY, Smith TL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
62. Krasner N, Johnson PJ, Portmann B, Watkinson G, MacSween RN, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut 1979;20:255-8.
63. Melia WM, Johnson PJ, Neuberger J, Zaman S, Portmann BC, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alfa-fetoprotein estimation. Gastroenterology 1984;87:660-3.
64. Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Hepatocellular carcinoma in primary biliary cirrhosis. J Hepatol 1994;21:315-6.
65. Lööf L, Adami HO, Sparén P, Danielson A, Eriksson LS, Hultcrantz R, et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 1994;20:101-4.
66. Jones DEJ, Metcalff JV, Collier JD, Bassendine MF, James OFW. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 1997;26:1138-42.
67. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 1999;29:1396-8.
68. Caballeria L, Parés A, Castells A, Ginés A, Bru C, Rodés J. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 2001;96:1160-3.
69. Shibuya A, Tanaka K, Miyajawa H, Shibata M, Takatori M, Sekiyama K, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 2002;35:1172-8.
70. Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 1989;10:846-50.
71. Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis L, et al. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology 1996;23:1148-53.
72. Van Dam GM, Verbaan BW, Therneau TM, Dickson ER, Malinchoc M, Murtaugh PA, et al. Primary biliary cirrhosis: Dutch application of the Mayo model before and after orthotopic liver transplantation. Hepatogastroenterology 1997;44:732-43.
73. Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, et al. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 1999;19:115-21.
74. Goudie BM, Burt AD, Macfarlane GJ, Boyle P, Gillis CR, MacSween RN, et al. Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol 1989;84:713-6.
75. Klion FM, Fabry TL, Palmer M, Schaffner F. Prediction of survival of patients with primary biliary cirrhosis: examination of the Mayo clinic model on a group of patients with known endpoint. Gastroenterology 1992;102:310-3.
76. Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstem K, et al. Ursodeoxycholic acid (UDCA) treatment of primary biliary cirrhosis: Clinical and histologic results of a prospective double-blind study. Gastroenterology 1989;97:1268-74.
77. Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-7.
78. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey R, Blendis LM, Ghent CN, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic in primary biliary cirrhosis. Hepatology 1994;19:1149-56.
79. Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murthaugh PA, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-90.
80. Bonnand AM, Heathcote EJ, Lindor KD, Poupon RE. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Hepatology 1999;29:39-43.
81. Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 1999;29:644-7.